| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | poly(G) binding | 5.05e-08 | 10 | 16 | 3 | GO:0034046 | |
| GeneOntologyMolecularFunction | mRNA 3'-UTR binding | 1.88e-06 | 276 | 16 | 5 | GO:0003730 | |
| GeneOntologyMolecularFunction | poly-purine tract binding | 3.23e-06 | 37 | 16 | 3 | GO:0070717 | |
| GeneOntologyMolecularFunction | N6-methyladenosine-containing RNA reader activity | 6.28e-05 | 15 | 16 | 2 | GO:1990247 | |
| GeneOntologyMolecularFunction | single-stranded RNA binding | 8.88e-05 | 111 | 16 | 3 | GO:0003727 | |
| GeneOntologyMolecularFunction | mRNA binding | 1.59e-04 | 694 | 16 | 5 | GO:0003729 | |
| GeneOntologyMolecularFunction | protein-RNA adaptor activity | 1.64e-04 | 24 | 16 | 2 | GO:0140517 | |
| GeneOntologyMolecularFunction | telomerase RNA binding | 1.79e-04 | 25 | 16 | 2 | GO:0070034 | |
| GeneOntologyMolecularFunction | mRNA 5'-UTR binding | 1.79e-04 | 25 | 16 | 2 | GO:0048027 | |
| GeneOntologyMolecularFunction | poly(A) binding | 2.41e-04 | 29 | 16 | 2 | GO:0008143 | |
| GeneOntologyMolecularFunction | poly-pyrimidine tract binding | 4.38e-04 | 39 | 16 | 2 | GO:0008187 | |
| GeneOntologyMolecularFunction | molecular condensate scaffold activity | 5.09e-04 | 42 | 16 | 2 | GO:0140693 | |
| GeneOntologyMolecularFunction | single-stranded DNA binding | 5.04e-03 | 134 | 16 | 2 | GO:0003697 | |
| GeneOntologyBiologicalProcess | regulation of mRNA stability | 1.47e-06 | 292 | 15 | 5 | GO:0043488 | |
| GeneOntologyBiologicalProcess | mRNA metabolic process | 1.58e-06 | 917 | 15 | 7 | GO:0016071 | |
| GeneOntologyBiologicalProcess | regulation of RNA stability | 1.91e-06 | 308 | 15 | 5 | GO:0043487 | |
| GeneOntologyBiologicalProcess | regulation of mRNA catabolic process | 1.94e-06 | 309 | 15 | 5 | GO:0061013 | |
| GeneOntologyBiologicalProcess | regulation of cytoplasmic translation | 2.38e-06 | 37 | 15 | 3 | GO:2000765 | |
| GeneOntologyBiologicalProcess | mRNA catabolic process | 4.87e-06 | 373 | 15 | 5 | GO:0006402 | |
| GeneOntologyBiologicalProcess | RNA catabolic process | 9.94e-06 | 432 | 15 | 5 | GO:0006401 | |
| GeneOntologyBiologicalProcess | regulation of mRNA metabolic process | 1.12e-05 | 443 | 15 | 5 | GO:1903311 | |
| GeneOntologyBiologicalProcess | nucleic acid catabolic process | 1.41e-05 | 464 | 15 | 5 | GO:0141188 | |
| GeneOntologyBiologicalProcess | RNA splicing | 2.05e-05 | 502 | 15 | 5 | GO:0008380 | |
| GeneOntologyBiologicalProcess | mRNA stabilization | 2.20e-05 | 77 | 15 | 3 | GO:0048255 | |
| GeneOntologyBiologicalProcess | alternative mRNA splicing, via spliceosome | 2.38e-05 | 79 | 15 | 3 | GO:0000380 | |
| GeneOntologyBiologicalProcess | CRD-mediated mRNA stabilization | 2.70e-05 | 11 | 15 | 2 | GO:0070934 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA catabolic process | 3.18e-05 | 87 | 15 | 3 | GO:1902373 | |
| GeneOntologyBiologicalProcess | negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 3.24e-05 | 12 | 15 | 2 | GO:1900152 | |
| GeneOntologyBiologicalProcess | RNA stabilization | 3.29e-05 | 88 | 15 | 3 | GO:0043489 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA catabolic process | 4.97e-05 | 101 | 15 | 3 | GO:1902369 | |
| GeneOntologyBiologicalProcess | positive regulation of cytoplasmic translation | 6.67e-05 | 17 | 15 | 2 | GO:2000767 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA metabolic process | 7.32e-05 | 115 | 15 | 3 | GO:1903312 | |
| GeneOntologyBiologicalProcess | dendrite development | 8.10e-05 | 335 | 15 | 4 | GO:0016358 | |
| GeneOntologyBiologicalProcess | nucleobase-containing compound catabolic process | 9.77e-05 | 696 | 15 | 5 | GO:0034655 | |
| GeneOntologyBiologicalProcess | positive regulation of catabolic process | 1.01e-04 | 701 | 15 | 5 | GO:0009896 | |
| GeneOntologyBiologicalProcess | mRNA splicing, via spliceosome | 1.05e-04 | 358 | 15 | 4 | GO:0000398 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 1.05e-04 | 358 | 15 | 4 | GO:0000377 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions | 1.09e-04 | 362 | 15 | 4 | GO:0000375 | |
| GeneOntologyBiologicalProcess | regulation of catabolic process | 1.54e-04 | 1252 | 15 | 6 | GO:0009894 | |
| GeneOntologyBiologicalProcess | positive regulation of translation | 1.64e-04 | 151 | 15 | 3 | GO:0045727 | |
| GeneOntologyBiologicalProcess | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 1.71e-04 | 27 | 15 | 2 | GO:1900151 | |
| GeneOntologyBiologicalProcess | cytoplasmic translation | 2.41e-04 | 172 | 15 | 3 | GO:0002181 | |
| GeneOntologyBiologicalProcess | dendrite morphogenesis | 3.64e-04 | 198 | 15 | 3 | GO:0048813 | |
| GeneOntologyBiologicalProcess | mRNA destabilization | 4.09e-04 | 206 | 15 | 3 | GO:0061157 | |
| GeneOntologyBiologicalProcess | RNA processing | 4.13e-04 | 1500 | 15 | 6 | GO:0006396 | |
| GeneOntologyBiologicalProcess | regulation of RNA splicing | 4.15e-04 | 207 | 15 | 3 | GO:0043484 | |
| GeneOntologyBiologicalProcess | RNA destabilization | 4.39e-04 | 211 | 15 | 3 | GO:0050779 | |
| GeneOntologyBiologicalProcess | positive regulation of mRNA catabolic process | 4.39e-04 | 211 | 15 | 3 | GO:0061014 | |
| GeneOntologyBiologicalProcess | RNA localization | 4.76e-04 | 217 | 15 | 3 | GO:0006403 | |
| GeneOntologyBiologicalProcess | mRNA processing | 5.44e-04 | 551 | 15 | 4 | GO:0006397 | |
| GeneOntologyBiologicalProcess | positive regulation of mRNA metabolic process | 7.96e-04 | 259 | 15 | 3 | GO:1903313 | |
| GeneOntologyBiologicalProcess | regulation of alternative mRNA splicing, via spliceosome | 8.25e-04 | 59 | 15 | 2 | GO:0000381 | |
| GeneOntologyBiologicalProcess | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 1.00e-03 | 65 | 15 | 2 | GO:0000288 | |
| GeneOntologyBiologicalProcess | post-transcriptional regulation of gene expression | 1.01e-03 | 1153 | 15 | 5 | GO:0010608 | |
| GeneOntologyBiologicalProcess | synapse organization | 1.23e-03 | 685 | 15 | 4 | GO:0050808 | |
| GeneOntologyBiologicalProcess | synaptic transmission, GABAergic | 1.29e-03 | 74 | 15 | 2 | GO:0051932 | |
| GeneOntologyBiologicalProcess | synapse assembly | 1.31e-03 | 308 | 15 | 3 | GO:0007416 | |
| GeneOntologyBiologicalProcess | telomere maintenance via telomerase | 1.40e-03 | 77 | 15 | 2 | GO:0007004 | |
| GeneOntologyBiologicalProcess | vesicle-mediated transport in synapse | 1.48e-03 | 321 | 15 | 3 | GO:0099003 | |
| GeneOntologyBiologicalProcess | RNA-templated DNA biosynthetic process | 1.62e-03 | 83 | 15 | 2 | GO:0006278 | |
| GeneOntologyBiologicalProcess | telomere maintenance via telomere lengthening | 1.91e-03 | 90 | 15 | 2 | GO:0010833 | |
| GeneOntologyBiologicalProcess | regulation of receptor internalization | 2.12e-03 | 95 | 15 | 2 | GO:0002090 | |
| GeneOntologyBiologicalProcess | axo-dendritic transport | 2.25e-03 | 98 | 15 | 2 | GO:0008088 | |
| GeneOntologyBiologicalProcess | transmission of nerve impulse | 2.93e-03 | 112 | 15 | 2 | GO:0019226 | |
| GeneOntologyBiologicalProcess | negative regulation of catabolic process | 3.14e-03 | 418 | 15 | 3 | GO:0009895 | |
| GeneOntologyBiologicalProcess | regulation of neurotransmitter secretion | 3.25e-03 | 118 | 15 | 2 | GO:0046928 | |
| GeneOntologyBiologicalProcess | synaptic vesicle exocytosis | 3.63e-03 | 125 | 15 | 2 | GO:0016079 | |
| GeneOntologyBiologicalProcess | regulation of mRNA splicing, via spliceosome | 3.86e-03 | 129 | 15 | 2 | GO:0048024 | |
| GeneOntologyBiologicalProcess | nuclear-transcribed mRNA catabolic process | 4.04e-03 | 132 | 15 | 2 | GO:0000956 | |
| GeneOntologyBiologicalProcess | cell junction organization | 4.44e-03 | 974 | 15 | 4 | GO:0034330 | |
| GeneOntologyBiologicalProcess | dendritic spine development | 4.60e-03 | 141 | 15 | 2 | GO:0060996 | |
| GeneOntologyBiologicalProcess | regulation of neurotransmitter transport | 4.60e-03 | 141 | 15 | 2 | GO:0051588 | |
| GeneOntologyBiologicalProcess | mRNA transport | 4.85e-03 | 145 | 15 | 2 | GO:0051028 | |
| GeneOntologyBiologicalProcess | regulation of translation | 5.01e-03 | 494 | 15 | 3 | GO:0006417 | |
| GeneOntologyBiologicalProcess | regulation of receptor-mediated endocytosis | 5.59e-03 | 156 | 15 | 2 | GO:0048259 | |
| GeneOntologyBiologicalProcess | regulation of mRNA processing | 5.73e-03 | 158 | 15 | 2 | GO:0050684 | |
| GeneOntologyCellularComponent | dendrite | 1.58e-06 | 858 | 16 | 7 | GO:0030425 | |
| GeneOntologyCellularComponent | dendritic tree | 1.61e-06 | 860 | 16 | 7 | GO:0097447 | |
| GeneOntologyCellularComponent | CRD-mediated mRNA stability complex | 8.22e-06 | 6 | 16 | 2 | GO:0070937 | |
| GeneOntologyCellularComponent | somatodendritic compartment | 1.70e-05 | 1228 | 16 | 7 | GO:0036477 | |
| GeneOntologyCellularComponent | dendritic spine | 2.86e-05 | 242 | 16 | 4 | GO:0043197 | |
| GeneOntologyCellularComponent | neuron spine | 3.10e-05 | 247 | 16 | 4 | GO:0044309 | |
| GeneOntologyCellularComponent | cytoplasmic ribonucleoprotein granule | 4.32e-05 | 269 | 16 | 4 | GO:0036464 | |
| GeneOntologyCellularComponent | ribonucleoprotein granule | 5.56e-05 | 287 | 16 | 4 | GO:0035770 | |
| GeneOntologyCellularComponent | dendritic spine head | 6.55e-05 | 16 | 16 | 2 | GO:0044327 | |
| GeneOntologyCellularComponent | postsynapse | 6.91e-05 | 1018 | 16 | 6 | GO:0098794 | |
| GeneOntologyCellularComponent | telomerase holoenzyme complex | 1.63e-04 | 25 | 16 | 2 | GO:0005697 | |
| GeneOntologyCellularComponent | ribonucleoprotein complex | 1.67e-04 | 1194 | 16 | 6 | GO:1990904 | |
| GeneOntologyCellularComponent | glutamatergic synapse | 2.75e-04 | 817 | 16 | 5 | GO:0098978 | |
| GeneOntologyCellularComponent | postsynaptic cytosol | 5.33e-04 | 45 | 16 | 2 | GO:0099524 | |
| GeneOntologyCellularComponent | perikaryon | 6.05e-04 | 223 | 16 | 3 | GO:0043204 | |
| GeneOntologyCellularComponent | presynaptic cytosol | 6.33e-04 | 49 | 16 | 2 | GO:0099523 | |
| GeneOntologyCellularComponent | growth cone | 7.96e-04 | 245 | 16 | 3 | GO:0030426 | |
| GeneOntologyCellularComponent | site of polarized growth | 8.73e-04 | 253 | 16 | 3 | GO:0030427 | |
| GeneOntologyCellularComponent | cytosolic region | 1.29e-03 | 70 | 16 | 2 | GO:0099522 | |
| GeneOntologyCellularComponent | Cajal body | 1.85e-03 | 84 | 16 | 2 | GO:0015030 | |
| GeneOntologyCellularComponent | cytoplasmic stress granule | 2.40e-03 | 96 | 16 | 2 | GO:0010494 | |
| GeneOntologyCellularComponent | catalytic step 2 spliceosome | 2.45e-03 | 97 | 16 | 2 | GO:0071013 | |
| GeneOntologyCellularComponent | P-body | 2.71e-03 | 102 | 16 | 2 | GO:0000932 | |
| GeneOntologyCellularComponent | neuronal cell body | 3.13e-03 | 835 | 16 | 4 | GO:0043025 | |
| GeneOntologyCellularComponent | neuron projection cytoplasm | 3.14e-03 | 110 | 16 | 2 | GO:0120111 | |
| GeneOntologyCellularComponent | chromosomal region | 3.74e-03 | 421 | 16 | 3 | GO:0098687 | |
| GeneOntologyCellularComponent | presynapse | 3.88e-03 | 886 | 16 | 4 | GO:0098793 | |
| GeneOntologyCellularComponent | filopodium | 3.90e-03 | 123 | 16 | 2 | GO:0030175 | |
| GeneOntologyCellularComponent | distal axon | 4.10e-03 | 435 | 16 | 3 | GO:0150034 | |
| GeneOntologyCellularComponent | cell body | 4.59e-03 | 929 | 16 | 4 | GO:0044297 | |
| GeneOntologyCellularComponent | fibrillar center | 6.20e-03 | 156 | 16 | 2 | GO:0001650 | |
| GeneOntologyCellularComponent | axon terminus | 1.10e-02 | 210 | 16 | 2 | GO:0043679 | |
| GeneOntologyCellularComponent | spliceosomal complex | 1.15e-02 | 215 | 16 | 2 | GO:0005681 | |
| GeneOntologyCellularComponent | neuron projection terminus | 1.34e-02 | 233 | 16 | 2 | GO:0044306 | |
| GeneOntologyCellularComponent | chromosome, centromeric region | 1.84e-02 | 276 | 16 | 2 | GO:0000775 | |
| GeneOntologyCellularComponent | presynaptic membrane | 1.86e-02 | 277 | 16 | 2 | GO:0042734 | |
| GeneOntologyCellularComponent | actin-based cell projection | 1.87e-02 | 278 | 16 | 2 | GO:0098858 | |
| HumanPheno | Dyscalculia | 3.18e-06 | 24 | 7 | 3 | HP:0002442 | |
| HumanPheno | Abnormal head movements | 1.78e-05 | 42 | 7 | 3 | HP:0002457 | |
| MousePheno | abnormal nerve fiber response | 8.05e-05 | 16 | 12 | 2 | MP:0003477 | |
| Domain | UBA-like | 1.70e-05 | 64 | 15 | 3 | IPR009060 | |
| Domain | RRM_1 | 1.85e-05 | 208 | 15 | 4 | PF00076 | |
| Domain | RRM | 2.19e-05 | 217 | 15 | 4 | SM00360 | |
| Domain | RRM_dom | 2.61e-05 | 227 | 15 | 4 | IPR000504 | |
| Domain | RRM | 2.75e-05 | 230 | 15 | 4 | PS50102 | |
| Domain | - | 3.46e-05 | 244 | 15 | 4 | 3.30.70.330 | |
| Domain | Nucleotide-bd_a/b_plait | 4.31e-05 | 258 | 15 | 4 | IPR012677 | |
| Domain | - | 1.25e-04 | 21 | 15 | 2 | 1.10.720.30 | |
| Domain | SAP | 1.38e-04 | 22 | 15 | 2 | PF02037 | |
| Domain | SAP | 1.51e-04 | 23 | 15 | 2 | SM00513 | |
| Domain | SAP | 1.79e-04 | 25 | 15 | 2 | PS50800 | |
| Domain | SAP_dom | 1.79e-04 | 25 | 15 | 2 | IPR003034 | |
| Domain | UBA | 2.59e-04 | 30 | 15 | 2 | SM00165 | |
| Domain | UBA | 3.73e-04 | 36 | 15 | 2 | PF00627 | |
| Domain | KH_1 | 4.16e-04 | 38 | 15 | 2 | PF00013 | |
| Domain | - | 4.39e-04 | 39 | 15 | 2 | 3.30.1370.10 | |
| Domain | KH | 4.61e-04 | 40 | 15 | 2 | SM00322 | |
| Domain | KH_dom | 4.61e-04 | 40 | 15 | 2 | IPR004087 | |
| Domain | KH_TYPE_1 | 5.09e-04 | 42 | 15 | 2 | PS50084 | |
| Domain | KH_dom_type_1 | 5.59e-04 | 44 | 15 | 2 | IPR004088 | |
| Domain | UBA | 5.59e-04 | 44 | 15 | 2 | IPR015940 | |
| Domain | UBA | 6.37e-04 | 47 | 15 | 2 | PS50030 | |
| Domain | SPRY | 2.17e-03 | 87 | 15 | 2 | SM00449 | |
| Domain | SPRY | 2.52e-03 | 94 | 15 | 2 | PF00622 | |
| Domain | SPRY_dom | 2.52e-03 | 94 | 15 | 2 | IPR003877 | |
| Domain | B30.2/SPRY | 2.57e-03 | 95 | 15 | 2 | IPR001870 | |
| Domain | B302_SPRY | 2.57e-03 | 95 | 15 | 2 | PS50188 | |
| Domain | ConA-like_dom | 1.30e-02 | 219 | 15 | 2 | IPR013320 | |
| Pathway | WP_MRNA_PROCESSING | 4.18e-07 | 451 | 11 | 6 | MM15946 | |
| Pathway | WP_MRNA_PROCESSING | 1.09e-04 | 126 | 11 | 3 | M39406 | |
| Pathway | REACTOME_METABOLISM_OF_RNA | 1.26e-04 | 724 | 11 | 5 | M16843 | |
| Pathway | REACTOME_MRNA_SPLICING | 4.33e-04 | 201 | 11 | 3 | MM15411 | |
| Pathway | REACTOME_MRNA_SPLICING | 5.06e-04 | 212 | 11 | 3 | M14033 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 1.10e-03 | 277 | 11 | 3 | MM15414 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 1.17e-03 | 283 | 11 | 3 | M13087 | |
| Pubmed | 1.07e-13 | 260 | 16 | 8 | 36199071 | ||
| Pubmed | 2.48e-11 | 136 | 16 | 6 | 26979993 | ||
| Pubmed | 4.34e-11 | 551 | 16 | 8 | 34728620 | ||
| Pubmed | 1.04e-10 | 615 | 16 | 8 | 31048545 | ||
| Pubmed | 3.34e-10 | 713 | 16 | 8 | 29802200 | ||
| Pubmed | 3.77e-10 | 421 | 16 | 7 | 34650049 | ||
| Pubmed | 4.43e-10 | 90 | 16 | 5 | 23151878 | ||
| Pubmed | 4.54e-10 | 220 | 16 | 6 | 24550385 | ||
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | 5.47e-10 | 759 | 16 | 8 | 35915203 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | 8.86e-10 | 807 | 16 | 8 | 22681889 | |
| Pubmed | 1.70e-09 | 274 | 16 | 6 | 34244482 | ||
| Pubmed | 1.99e-09 | 121 | 16 | 5 | 34029587 | ||
| Pubmed | SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling. | 2.66e-09 | 558 | 16 | 7 | 27591049 | |
| Pubmed | Cellular RNA binding proteins NS1-BP and hnRNP K regulate influenza A virus RNA splicing. | 2.70e-09 | 40 | 16 | 4 | 23825951 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 3.30e-09 | 954 | 16 | 8 | 36373674 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 4.65e-09 | 605 | 16 | 7 | 28977666 | |
| Pubmed | The PRMT5/WDR77 complex regulates alternative splicing through ZNF326 in breast cancer. | 5.30e-09 | 147 | 16 | 5 | 28977470 | |
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | 5.88e-09 | 626 | 16 | 7 | 33644029 | |
| Pubmed | 6.84e-09 | 346 | 16 | 6 | 25324306 | ||
| Pubmed | 7.79e-09 | 652 | 16 | 7 | 31180492 | ||
| Pubmed | Proteomic and functional analysis of Argonaute-containing mRNA-protein complexes in human cells. | 1.16e-08 | 57 | 16 | 4 | 17932509 | |
| Pubmed | Nucleolar localization of DGCR8 and identification of eleven DGCR8-associated proteins. | 2.28e-08 | 13 | 16 | 3 | 17765891 | |
| Pubmed | TRIM28-mediated nucleocapsid protein SUMOylation enhances SARS-CoV-2 virulence. | 2.49e-08 | 430 | 16 | 6 | 38172120 | |
| Pubmed | Profiling of Parkin-binding partners using tandem affinity purification. | 2.67e-08 | 203 | 16 | 5 | 24244333 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | 2.83e-08 | 1257 | 16 | 8 | 36526897 | |
| Pubmed | 3.64e-08 | 216 | 16 | 5 | 37640791 | ||
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | 3.81e-08 | 462 | 16 | 6 | 31138677 | |
| Pubmed | 3.85e-08 | 463 | 16 | 6 | 34901782 | ||
| Pubmed | 4.68e-08 | 847 | 16 | 7 | 35850772 | ||
| Pubmed | LINKIN, a new transmembrane protein necessary for cell adhesion. | 4.77e-08 | 480 | 16 | 6 | 25437307 | |
| Pubmed | 5.41e-08 | 17 | 16 | 3 | 12388589 | ||
| Pubmed | 5.65e-08 | 494 | 16 | 6 | 26831064 | ||
| Pubmed | CircRNA-SORE mediates sorafenib resistance in hepatocellular carcinoma by stabilizing YBX1. | 6.49e-08 | 18 | 16 | 3 | 33361760 | |
| Pubmed | 6.69e-08 | 244 | 16 | 5 | 29884807 | ||
| Pubmed | 6.83e-08 | 245 | 16 | 5 | 35652658 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | 7.08e-08 | 1415 | 16 | 8 | 28515276 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | 7.47e-08 | 1425 | 16 | 8 | 30948266 | |
| Pubmed | SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9. | 8.83e-08 | 258 | 16 | 5 | 37794589 | |
| Pubmed | Disruption of the lamin A and matrin-3 interaction by myopathic LMNA mutations. | 9.67e-08 | 96 | 16 | 4 | 25948554 | |
| Pubmed | The RNA-binding protein Snd1/Tudor-SN regulates hypoxia-responsive gene expression. | 1.01e-07 | 97 | 16 | 4 | 37151849 | |
| Pubmed | 1.19e-07 | 971 | 16 | 7 | 33306668 | ||
| Pubmed | 1.61e-07 | 109 | 16 | 4 | 12226669 | ||
| Pubmed | 1.61e-07 | 109 | 16 | 4 | 29511296 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 1.70e-07 | 1024 | 16 | 7 | 24711643 | |
| Pubmed | 1.93e-07 | 114 | 16 | 4 | 31553912 | ||
| Pubmed | The tandem Agenet domain of fragile X mental retardation protein interacts with FUS. | 1.98e-07 | 2 | 16 | 2 | 28424484 | |
| Pubmed | Visualization of RNA-protein interactions in living cells: FMRP and IMP1 interact on mRNAs. | 1.98e-07 | 2 | 16 | 2 | 15282548 | |
| Pubmed | 1.98e-07 | 2 | 16 | 2 | 21734271 | ||
| Pubmed | 2.00e-07 | 115 | 16 | 4 | 17332742 | ||
| Pubmed | 2.97e-07 | 655 | 16 | 6 | 35819319 | ||
| Pubmed | 3.11e-07 | 660 | 16 | 6 | 32780723 | ||
| Pubmed | ARIH2 Is a Vif-Dependent Regulator of CUL5-Mediated APOBEC3G Degradation in HIV Infection. | 3.27e-07 | 336 | 16 | 5 | 31253590 | |
| Pubmed | SPOP attenuates migration and invasion of choriocarcinoma cells by promoting DHX9 degradation. | 3.28e-07 | 130 | 16 | 4 | 32905556 | |
| Pubmed | 3.47e-07 | 340 | 16 | 5 | 24332808 | ||
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | 3.64e-07 | 678 | 16 | 6 | 30209976 | |
| Pubmed | 3.80e-07 | 1153 | 16 | 7 | 29845934 | ||
| Pubmed | 3.83e-07 | 347 | 16 | 5 | 16033648 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | 3.85e-07 | 1155 | 16 | 7 | 20360068 | |
| Pubmed | 4.65e-07 | 707 | 16 | 6 | 19738201 | ||
| Pubmed | 4.81e-07 | 711 | 16 | 6 | 33022573 | ||
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | 4.93e-07 | 714 | 16 | 6 | 28302793 | |
| Pubmed | 5.39e-07 | 725 | 16 | 6 | 27025967 | ||
| Pubmed | HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137. | 5.51e-07 | 148 | 16 | 4 | 32538781 | |
| Pubmed | 5.65e-07 | 36 | 16 | 3 | 17289661 | ||
| Pubmed | 5.65e-07 | 731 | 16 | 6 | 29298432 | ||
| Pubmed | ALS-related FUS mutations alter axon growth in motoneurons and affect HuD/ELAVL4 and FMRP activity. | 5.95e-07 | 3 | 16 | 2 | 34471224 | |
| Pubmed | Heterogeneous nuclear ribonucleoproteins R and Q accumulate in pathological inclusions in FTLD-FUS. | 5.95e-07 | 3 | 16 | 2 | 30755280 | |
| Pubmed | 6.29e-07 | 153 | 16 | 4 | 28225217 | ||
| Pubmed | Identification of a USP9X Substrate NFX1-123 by SILAC-Based Quantitative Proteomics. | 6.32e-07 | 384 | 16 | 5 | 31059266 | |
| Pubmed | WW domains provide a platform for the assembly of multiprotein networks. | 6.46e-07 | 154 | 16 | 4 | 16055720 | |
| Pubmed | 6.82e-07 | 390 | 16 | 5 | 17643375 | ||
| Pubmed | The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatin. | 7.72e-07 | 400 | 16 | 5 | 35013556 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | 8.27e-07 | 1294 | 16 | 7 | 30804502 | |
| Pubmed | ARMC5 is part of an RPB1-specific ubiquitin ligase implicated in adrenal hyperplasia. | 8.71e-07 | 166 | 16 | 4 | 35687106 | |
| Pubmed | 9.14e-07 | 168 | 16 | 4 | 39066279 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | 9.36e-07 | 1318 | 16 | 7 | 30463901 | |
| Pubmed | 1.00e-06 | 172 | 16 | 4 | 26336360 | ||
| Pubmed | 1.02e-06 | 1335 | 16 | 7 | 29229926 | ||
| Pubmed | 1.02e-06 | 809 | 16 | 6 | 32129710 | ||
| Pubmed | 1.04e-06 | 425 | 16 | 5 | 21081503 | ||
| Pubmed | 1.05e-06 | 174 | 16 | 4 | 35031058 | ||
| Pubmed | RNA-binding proteins in neurological development and disease. | 1.19e-06 | 4 | 16 | 2 | 32865115 | |
| Pubmed | 1.25e-06 | 441 | 16 | 5 | 31239290 | ||
| Pubmed | 1.69e-06 | 469 | 16 | 5 | 37314180 | ||
| Pubmed | Ablation of the oncogenic transcription factor ERG by deubiquitinase inhibition in prostate cancer. | 1.74e-06 | 52 | 16 | 3 | 24591637 | |
| Pubmed | HDAC6 activity is not required for basal autophagic flux in metastatic prostate cancer cells. | 1.74e-06 | 52 | 16 | 3 | 26643866 | |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | 1.83e-06 | 477 | 16 | 5 | 31300519 | |
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | 2.01e-06 | 486 | 16 | 5 | 30940648 | |
| Pubmed | 2.06e-06 | 206 | 16 | 4 | 22174317 | ||
| Pubmed | 2.11e-06 | 491 | 16 | 5 | 22623428 | ||
| Pubmed | IFIT1 is an antiviral protein that recognizes 5'-triphosphate RNA. | 2.43e-06 | 58 | 16 | 3 | 21642987 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | 2.57e-06 | 949 | 16 | 6 | 36574265 | |
| Pubmed | The RNA-binding protein HuR is a novel target of Pirh2 E3 ubiquitin ligase. | 2.67e-06 | 220 | 16 | 4 | 34091597 | |
| Pubmed | 2.80e-06 | 963 | 16 | 6 | 28671696 | ||
| Pubmed | 2.82e-06 | 223 | 16 | 4 | 20020773 | ||
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | 3.27e-06 | 989 | 16 | 6 | 36424410 | |
| Pubmed | A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase. | 3.30e-06 | 232 | 16 | 4 | 25515538 | |
| Pubmed | 4.03e-06 | 244 | 16 | 4 | 30349055 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | 5.48e-06 | 1082 | 16 | 6 | 38697112 | |
| Pubmed | 5.55e-06 | 8 | 16 | 2 | 12183049 | ||
| Interaction | DAZL interactions | 5.93e-10 | 145 | 15 | 6 | int:DAZL | |
| Interaction | CELF1 interactions | 6.60e-10 | 288 | 15 | 7 | int:CELF1 | |
| Interaction | PRMT1 interactions | 3.52e-09 | 929 | 15 | 9 | int:PRMT1 | |
| Interaction | RBM45 interactions | 5.06e-09 | 207 | 15 | 6 | int:RBM45 | |
| Interaction | PRC1 interactions | GAR1 HNRNPDL IGF2BP1 ARHGAP33 HNRNPU FUS FMR1 HNRNPUL1 HNRNPR | 5.29e-09 | 973 | 15 | 9 | int:PRC1 |
| Interaction | NEDD8 interactions | 5.72e-09 | 393 | 15 | 7 | int:NEDD8 | |
| Interaction | SYNCRIP interactions | 1.33e-08 | 721 | 15 | 8 | int:SYNCRIP | |
| Interaction | TRIM31 interactions | 1.55e-08 | 454 | 15 | 7 | int:TRIM31 | |
| Interaction | LSM14A interactions | 1.98e-08 | 260 | 15 | 6 | int:LSM14A | |
| Interaction | BTRC interactions | 2.34e-08 | 775 | 15 | 8 | int:BTRC | |
| Interaction | FZR1 interactions | 2.69e-08 | 1172 | 15 | 9 | int:FZR1 | |
| Interaction | WWP2 interactions | 4.37e-08 | 840 | 15 | 8 | int:WWP2 | |
| Interaction | IL7R interactions | 4.43e-08 | 141 | 15 | 5 | int:IL7R | |
| Interaction | DDRGK1 interactions | 4.67e-08 | 1249 | 15 | 9 | int:DDRGK1 | |
| Interaction | ZFR interactions | 4.72e-08 | 301 | 15 | 6 | int:ZFR | |
| Interaction | CYLD interactions | 5.64e-08 | 868 | 15 | 8 | int:CYLD | |
| Interaction | ARIH2 interactions | 6.07e-08 | 314 | 15 | 6 | int:ARIH2 | |
| Interaction | GLDC interactions | 6.91e-08 | 321 | 15 | 6 | int:GLDC | |
| Interaction | DDX5 interactions | 7.20e-08 | 568 | 15 | 7 | int:DDX5 | |
| Interaction | OBSL1 interactions | 7.59e-08 | 902 | 15 | 8 | int:OBSL1 | |
| Interaction | ILF2 interactions | 9.33e-08 | 590 | 15 | 7 | int:ILF2 | |
| Interaction | MYCN interactions | 1.06e-07 | 1373 | 15 | 9 | int:MYCN | |
| Interaction | HNRNPA0 interactions | 1.13e-07 | 349 | 15 | 6 | int:HNRNPA0 | |
| Interaction | HNRNPDL interactions | 1.45e-07 | 364 | 15 | 6 | int:HNRNPDL | |
| Interaction | HECTD1 interactions | 1.49e-07 | 984 | 15 | 8 | int:HECTD1 | |
| Interaction | SNRNP70 interactions | 1.49e-07 | 984 | 15 | 8 | int:SNRNP70 | |
| Interaction | HNRNPAB interactions | 1.63e-07 | 371 | 15 | 6 | int:HNRNPAB | |
| Interaction | SMC5 interactions | 1.68e-07 | 1000 | 15 | 8 | int:SMC5 | |
| Interaction | DDX3X interactions | 1.82e-07 | 651 | 15 | 7 | int:DDX3X | |
| Interaction | MATR3 interactions | 1.90e-07 | 655 | 15 | 7 | int:MATR3 | |
| Interaction | DHX9 interactions | 2.04e-07 | 662 | 15 | 7 | int:DHX9 | |
| Interaction | UFL1 interactions | 2.13e-07 | 1031 | 15 | 8 | int:UFL1 | |
| Interaction | RC3H2 interactions | 2.15e-07 | 667 | 15 | 7 | int:RC3H2 | |
| Interaction | HNRNPU interactions | 2.20e-07 | 1035 | 15 | 8 | int:HNRNPU | |
| Interaction | RC3H1 interactions | 2.38e-07 | 677 | 15 | 7 | int:RC3H1 | |
| Interaction | KIF20A interactions | 2.49e-07 | 1052 | 15 | 8 | int:KIF20A | |
| Interaction | TAF15 interactions | 2.85e-07 | 408 | 15 | 6 | int:TAF15 | |
| Interaction | PABPC1 interactions | 2.96e-07 | 699 | 15 | 7 | int:PABPC1 | |
| Interaction | RBMS1 interactions | 3.01e-07 | 207 | 15 | 5 | int:RBMS1 | |
| Interaction | SNRPC interactions | 4.43e-07 | 440 | 15 | 6 | int:SNRPC | |
| Interaction | FUS interactions | 5.07e-07 | 757 | 15 | 7 | int:FUS | |
| Interaction | CHD3 interactions | 5.07e-07 | 757 | 15 | 7 | int:CHD3 | |
| Interaction | DDX1 interactions | 5.98e-07 | 463 | 15 | 6 | int:DDX1 | |
| Interaction | NFX1 interactions | 6.21e-07 | 466 | 15 | 6 | int:NFX1 | |
| Interaction | SRPK1 interactions | 7.11e-07 | 477 | 15 | 6 | int:SRPK1 | |
| Interaction | BTF3 interactions | 7.30e-07 | 799 | 15 | 7 | int:BTF3 | |
| Interaction | SNRPA interactions | 7.56e-07 | 482 | 15 | 6 | int:SNRPA | |
| Interaction | PRMT8 interactions | 8.74e-07 | 104 | 15 | 4 | int:PRMT8 | |
| Interaction | IGF2BP1 interactions | 1.03e-06 | 508 | 15 | 6 | int:IGF2BP1 | |
| Interaction | CUL7 interactions | 1.06e-06 | 845 | 15 | 7 | int:CUL7 | |
| Interaction | PSPC1 interactions | 1.11e-06 | 515 | 15 | 6 | int:PSPC1 | |
| Interaction | HNRNPK interactions | 1.13e-06 | 853 | 15 | 7 | int:HNRNPK | |
| Interaction | CPSF6 interactions | 1.26e-06 | 526 | 15 | 6 | int:CPSF6 | |
| Interaction | SMN2 interactions | 1.26e-06 | 114 | 15 | 4 | int:SMN2 | |
| Interaction | PPIE interactions | 1.39e-06 | 282 | 15 | 5 | int:PPIE | |
| Interaction | ITFG1 interactions | 1.47e-06 | 540 | 15 | 6 | int:ITFG1 | |
| Interaction | CAND1 interactions | 1.55e-06 | 894 | 15 | 7 | int:CAND1 | |
| Interaction | ILF3 interactions | 1.58e-06 | 896 | 15 | 7 | int:ILF3 | |
| Interaction | RBM14 interactions | 1.68e-06 | 553 | 15 | 6 | int:RBM14 | |
| Interaction | RIOK1 interactions | 1.85e-06 | 562 | 15 | 6 | int:RIOK1 | |
| Interaction | HNRNPH3 interactions | 1.91e-06 | 301 | 15 | 5 | int:HNRNPH3 | |
| Interaction | CUL5 interactions | 1.95e-06 | 567 | 15 | 6 | int:CUL5 | |
| Interaction | UPF1 interactions | 2.24e-06 | 581 | 15 | 6 | int:UPF1 | |
| Interaction | CUL2 interactions | 2.48e-06 | 591 | 15 | 6 | int:CUL2 | |
| Interaction | EFTUD2 interactions | 2.85e-06 | 1449 | 15 | 8 | int:EFTUD2 | |
| Interaction | RBM42 interactions | 3.04e-06 | 331 | 15 | 5 | int:RBM42 | |
| Interaction | CPEB1 interactions | 3.39e-06 | 146 | 15 | 4 | int:CPEB1 | |
| Interaction | WWOX interactions | 3.49e-06 | 627 | 15 | 6 | int:WWOX | |
| Interaction | BRD7 interactions | 3.82e-06 | 637 | 15 | 6 | int:BRD7 | |
| Interaction | HNRNPD interactions | 3.86e-06 | 638 | 15 | 6 | int:HNRNPD | |
| Interaction | FAM120A interactions | 3.94e-06 | 349 | 15 | 5 | int:FAM120A | |
| Interaction | KIF23 interactions | 4.03e-06 | 1031 | 15 | 7 | int:KIF23 | |
| Interaction | MTERF3 interactions | 4.22e-06 | 354 | 15 | 5 | int:MTERF3 | |
| Interaction | RBM39 interactions | 4.32e-06 | 1042 | 15 | 7 | int:RBM39 | |
| Interaction | RALY interactions | 4.34e-06 | 356 | 15 | 5 | int:RALY | |
| Interaction | WDR77 interactions | 4.65e-06 | 361 | 15 | 5 | int:WDR77 | |
| Interaction | ZBTB7B interactions | 4.97e-06 | 366 | 15 | 5 | int:ZBTB7B | |
| Interaction | NUPR1 interactions | 5.71e-06 | 683 | 15 | 6 | int:NUPR1 | |
| Interaction | RNF113A interactions | 6.16e-06 | 692 | 15 | 6 | int:RNF113A | |
| Interaction | SNRPF interactions | 6.36e-06 | 385 | 15 | 5 | int:SNRPF | |
| Interaction | LARP7 interactions | 6.69e-06 | 1113 | 15 | 7 | int:LARP7 | |
| Interaction | IVNS1ABP interactions | 7.78e-06 | 180 | 15 | 4 | int:IVNS1ABP | |
| Interaction | CUL4B interactions | 8.24e-06 | 728 | 15 | 6 | int:CUL4B | |
| Interaction | AGO1 interactions | 8.31e-06 | 183 | 15 | 4 | int:AGO1 | |
| Interaction | PRKD1 interactions | 8.49e-06 | 184 | 15 | 4 | int:PRKD1 | |
| Interaction | HNRNPA2B1 interactions | 1.01e-05 | 754 | 15 | 6 | int:HNRNPA2B1 | |
| Interaction | DDX17 interactions | 1.04e-05 | 426 | 15 | 5 | int:DDX17 | |
| Interaction | RO60 interactions | 1.18e-05 | 200 | 15 | 4 | int:RO60 | |
| Interaction | ARMC5 interactions | 1.20e-05 | 201 | 15 | 4 | int:ARMC5 | |
| Interaction | PABPC4 interactions | 1.24e-05 | 442 | 15 | 5 | int:PABPC4 | |
| Interaction | MRPS26 interactions | 1.33e-05 | 448 | 15 | 5 | int:MRPS26 | |
| Interaction | CAPRIN1 interactions | 1.37e-05 | 451 | 15 | 5 | int:CAPRIN1 | |
| Interaction | NCL interactions | 1.39e-05 | 798 | 15 | 6 | int:NCL | |
| Interaction | BRCA1 interactions | 1.43e-05 | 1249 | 15 | 7 | int:BRCA1 | |
| Interaction | PFKL interactions | 1.54e-05 | 214 | 15 | 4 | int:PFKL | |
| Interaction | MIR138-1 interactions | 1.62e-05 | 68 | 15 | 3 | int:MIR138-1 | |
| Interaction | FBXW11 interactions | 1.72e-05 | 473 | 15 | 5 | int:FBXW11 | |
| Interaction | MECP2 interactions | 1.74e-05 | 1287 | 15 | 7 | int:MECP2 | |
| Interaction | MIR9-3 interactions | 1.77e-05 | 70 | 15 | 3 | int:MIR9-3 | |
| Interaction | OASL interactions | 1.81e-05 | 223 | 15 | 4 | int:OASL | |
| GeneFamily | RNA binding motif containing | 3.72e-06 | 213 | 10 | 4 | 725 | |
| Coexpression | HAY_BONE_MARROW_PRO_B | 7.99e-07 | 304 | 16 | 5 | M39208 | |
| Coexpression | GSE12366_PLASMA_CELL_VS_NAIVE_BCELL_DN | 5.46e-06 | 199 | 16 | 4 | M3175 | |
| Coexpression | SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP | 1.60e-05 | 82 | 16 | 3 | M9224 | |
| Coexpression | HOLLEMAN_PREDNISOLONE_RESISTANCE_ALL_UP | 6.60e-05 | 20 | 16 | 2 | M2558 | |
| Coexpression | HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_UP | 8.01e-05 | 22 | 16 | 2 | M2547 | |
| Coexpression | GAUTAM_EYE_CORNEA_FIBROBLASTS | 1.29e-04 | 165 | 16 | 3 | M43617 | |
| Coexpression | GSE14415_TCONV_VS_FOXP3_KO_INDUCED_TREG_UP | 1.46e-04 | 172 | 16 | 3 | M2963 | |
| Coexpression | FISCHER_DREAM_TARGETS | 2.12e-04 | 969 | 16 | 5 | M149 | |
| Coexpression | GSE22886_NAIVE_CD4_TCELL_VS_NKCELL_DN | 2.21e-04 | 198 | 16 | 3 | M4424 | |
| Coexpression | GSE17721_LPS_VS_CPG_2H_BMDC_DN | 2.28e-04 | 200 | 16 | 3 | M3991 | |
| Coexpression | GSE9006_HEALTHY_VS_TYPE_2_DIABETES_PBMC_AT_DX_UP | 2.28e-04 | 200 | 16 | 3 | M5781 | |
| Coexpression | BIDUS_METASTASIS_UP | 3.05e-04 | 221 | 16 | 3 | M15866 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 2.91e-05 | 171 | 16 | 3 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.12e-05 | 175 | 16 | 3 | cb974fbebe8cb58c7d3f7defabb4e056f2fee5fa | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.12e-05 | 175 | 16 | 3 | 96219e58dcb327fd27190be78193e7a0d611e62b | |
| ToppCell | facs-Heart-RA-18m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-05 | 178 | 16 | 3 | b505e2550860e777535ee95f29c936242fd607f1 | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.74e-05 | 186 | 16 | 3 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.74e-05 | 186 | 16 | 3 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | 10x_3'_v3|World / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.51e-05 | 198 | 16 | 3 | aabb8e9b162ae4cb26ea860c99decdbb51e379e1 | |
| ToppCell | megakaryocytic-CD34+_Megakaryoblast|megakaryocytic / Lineage and Cell class | 4.57e-05 | 199 | 16 | 3 | 99a65887d3c8a2cde26693dd74404b101bba9d58 | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_B-B_lineage-pre_pro_B_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.57e-05 | 199 | 16 | 3 | 5478b78349b5d8d57f30bb650dcbd5fdb84283d6 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.57e-05 | 199 | 16 | 3 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW13-Stem_cells|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 4.64e-05 | 200 | 16 | 3 | d933978b55fefe52cad599b36f6b47a0c7f71f96 | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 4.64e-05 | 200 | 16 | 3 | ad2a6da0b1ae7a9212a3c91e5eec4baa7481d8dc | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 4.64e-05 | 200 | 16 | 3 | 0350e5ffd36033099b7e32a1fdd790fff99790dc | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW13-Stem_cells-Neuroepithelial_cell|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 4.64e-05 | 200 | 16 | 3 | 3d932765c31aef1f80a118d51e8e66c50a758dbb | |
| ToppCell | 10x_5'_v1-Non-neoplastic|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.64e-05 | 200 | 16 | 3 | 88e94b067da1068b2ff1f95c730f2a49c66d7fe6 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-like|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.03e-03 | 134 | 16 | 2 | 64979e1a056b7406e1be39c5ebe2f8d731ac3c17 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P5-P5_2|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.06e-03 | 136 | 16 | 2 | 3e13dc0634f3b05e9f9e6c3193f843f62e603b78 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P5-P5_2-Sox4|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.06e-03 | 136 | 16 | 2 | 0185486c39700dd2f72d79be6d283494dd8379c9 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.27e-03 | 149 | 16 | 2 | 768877bade04ca0321593b8470b5011ad8270431 | |
| ToppCell | LPS-antiTNF-Lymphocytic_NKT-T_cells-Neutrophils|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.34e-03 | 153 | 16 | 2 | c4dcdcaa672929c1da870e9fb8ada1bb030ad12f | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cyth3_(Cyth3)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.34e-03 | 153 | 16 | 2 | 88ca2d2c2ab19fbee13e18951b993ee05dd30f67 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cyth3_(Cyth3)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.34e-03 | 153 | 16 | 2 | 553dff9688a1996d8f4ba16e60c683593d781389 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 1.39e-03 | 156 | 16 | 2 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM|Lung / Manually curated celltypes from each tissue | 1.41e-03 | 157 | 16 | 2 | af6eb2214340847bbab7cb209ea27cdc83b62a27 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.44e-03 | 159 | 16 | 2 | 22427ad4ad2e797e4664e7a7b0514094f22a18b2 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_B_plasma-Plasmablasts|bone_marrow / Manually curated celltypes from each tissue | 1.53e-03 | 164 | 16 | 2 | 67260e9f569f0acaeb0e65f69cde230f91cd3d26 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.59e-03 | 167 | 16 | 2 | 7cb1b11e8e24a10115e46ffbb74889e672a7a026 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.59e-03 | 167 | 16 | 2 | bb53a478b5d821d6d82c15bc4ed075b67682457c | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.59e-03 | 167 | 16 | 2 | e228b8373ffd4436e6b944e26d0fadf3ac289b21 | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.61e-03 | 168 | 16 | 2 | 2fb2d916eb5000a637240d38e47a9b4f61f9f83f | |
| ToppCell | COVID-19_Severe-CD4+_CTL|World / disease group, cell group and cell class | 1.63e-03 | 169 | 16 | 2 | 8c8168ac93a808d7b4756e4491db2b2979df1c1f | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4/8-lo|Lung / Manually curated celltypes from each tissue | 1.66e-03 | 171 | 16 | 2 | dfd4a15ab68ef5a9a1954b1b1540ae04017885a6 | |
| ToppCell | NS-critical-d_16-33-Epithelial-unknown_epithelial|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.68e-03 | 172 | 16 | 2 | c0b5e4889aef2f168d9f6db19a63b24bfd249316 | |
| ToppCell | Plasma_cells|World / lung cells shred on cell class, cell subclass, sample id | 1.70e-03 | 173 | 16 | 2 | 52a387e2a4694af61a9223a4c2ecf4e6f762c064 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Endothelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-03 | 176 | 16 | 2 | 27e5115fae5f0f63b333bc99fbf6a6d4c9182c46 | |
| ToppCell | (2)_Plasma_cells|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.78e-03 | 177 | 16 | 2 | ed3c936bb69f9bc7291b4f6cde1d204078117c48 | |
| ToppCell | -IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 1.78e-03 | 177 | 16 | 2 | ae2d2e138946535596fa30a55207f261cafda461 | |
| ToppCell | COVID-19_Severe-CD4+_CTL|COVID-19_Severe / disease group, cell group and cell class | 1.78e-03 | 177 | 16 | 2 | 34e9455790bae905dd91923792f4109d18b7686e | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-03 | 178 | 16 | 2 | 30ca37f70d267cc9b40ca3e211f16d30360c3e6b | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_granulocytic-granulocyte|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.82e-03 | 179 | 16 | 2 | 140dd7dbac48f5f07279f31bf971d7fbd41fa18b | |
| ToppCell | ILEUM-non-inflamed-(5)_Plasmablasts|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.82e-03 | 179 | 16 | 2 | 58c8996120637315dcbd1991a71516c09173051e | |
| ToppCell | BLOOD--(5)_Plasma| / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.84e-03 | 180 | 16 | 2 | 1ac0a0a715f4a36df0762bb0de44802d6ffa284c | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P5|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.84e-03 | 180 | 16 | 2 | 44988c34861df359a68376500c42a64fbcc4b431 | |
| ToppCell | BLOOD--(5)_Plasmablasts| / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.84e-03 | 180 | 16 | 2 | 4b9be1b19d4ecd0a3b924e4557a1ecfbcff2d705 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 1.86e-03 | 181 | 16 | 2 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | droplet-Lung-nan-3m-Epithelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-03 | 182 | 16 | 2 | cfba75c1ffc39ac76db9e8e27394731942882b30 | |
| ToppCell | droplet-Spleen-nan-18m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-03 | 182 | 16 | 2 | eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c | |
| ToppCell | droplet-Lung-nan-3m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-03 | 182 | 16 | 2 | 7e7c7a26460d3003cdf0c0ffb96208a566aa09a7 | |
| ToppCell | droplet-Lung-nan-3m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-03 | 182 | 16 | 2 | d836bfdc298ecd3558a973e393a329eb8bd59d79 | |
| ToppCell | ILEUM-inflamed-(5)_IgA_plasma_cells|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.90e-03 | 183 | 16 | 2 | a113558ca4220bac31f9336033dff82a618d9258 | |
| ToppCell | ILEUM-inflamed-(1)_T_cell-(1)_CD8_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.92e-03 | 184 | 16 | 2 | cef3ee2a4a0af961aa3b4c92150d423e841ae8c1 | |
| ToppCell | ILEUM-non-inflamed-(5)_IgA_plasma_cells|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.94e-03 | 185 | 16 | 2 | a44e418a75fd54fd8ba266a93c0e9e3ac2e6e315 | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 1.94e-03 | 185 | 16 | 2 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | ILEUM-non-inflamed-(5)_IgG_plasma_cells|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.94e-03 | 185 | 16 | 2 | 93b9a47357152ea95dfdfe8e7d111906a4adc551 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-T_cells-MAIT_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.94e-03 | 185 | 16 | 2 | 8314dc608bc837df3037e89afd9db39737374ebc | |
| ToppCell | (101)_plasma|World / immune cells in Peripheral Blood (logTPM normalization) | 1.96e-03 | 186 | 16 | 2 | 16267994c9ef1fb7118c4c665cbc96979ec2b703 | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 1.96e-03 | 186 | 16 | 2 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | droplet-Thymus-nan-3m-Lymphocytic-double_negative_T_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-03 | 186 | 16 | 2 | 11929e36d8c9b4c4bc2f5e912f139f474f91ab00 | |
| ToppCell | ILEUM-inflamed-(5)_Plasma|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.96e-03 | 186 | 16 | 2 | 4d105437487bf04f8cd6129b822d5c060af0bee8 | |
| ToppCell | ILEUM-inflamed-(1)_CD8_Trm|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.98e-03 | 187 | 16 | 2 | a77d7ae44f47410bd92fb3aa0f44dce891752b63 | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.98e-03 | 187 | 16 | 2 | 0099def970fbc828756fbf853eca2ce77b8cd342 | |
| ToppCell | ILEUM-non-inflamed-(5)_Plasma|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.98e-03 | 187 | 16 | 2 | c85f300c76043cc10935478591c9322b78845264 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-03 | 188 | 16 | 2 | 1efbc99bcd6542e5d9fa91edb7c4295167914786 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 2.01e-03 | 188 | 16 | 2 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.03e-03 | 189 | 16 | 2 | 0e8d1be3c406d1a393e18faccfe89116a8f82bcf | |
| ToppCell | ILEUM-inflamed-(5)_IgM_plasma_cells|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.03e-03 | 189 | 16 | 2 | fa9387d120cde6416998234c6ebd0ef74deed768 | |
| ToppCell | ILEUM-non-inflamed-(1)_T_cell-(1)_CD8_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.03e-03 | 189 | 16 | 2 | 2c8a2fb76ea002bac554bc1c761ce960b5e116e1 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-03 | 189 | 16 | 2 | f57200c93d39c9bce1adba0a6a1c178c028dd86b | |
| ToppCell | ILEUM-inflamed-(5)_Plasma-(5)_IgA_plasma_cells|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.03e-03 | 189 | 16 | 2 | a0634d72bfdd5f93877724ed6480b50a3a046f71 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD8-Trm/em_CD8|Lung / Manually curated celltypes from each tissue | 2.05e-03 | 190 | 16 | 2 | 74638e470ece8016465bbebc1756ffa6d605b25f | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 2.07e-03 | 191 | 16 | 2 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_NK-NK_CD56bright_CD16-|Lung / Manually curated celltypes from each tissue | 2.07e-03 | 191 | 16 | 2 | 12ce360dc149c85d5a22cfc1bf53d54aef79edc1 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_ILC|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.09e-03 | 192 | 16 | 2 | e981162f387a31111c0ae8355dbe9db5785c4838 | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-basal_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-03 | 192 | 16 | 2 | ec1fd2fb6e71f87189d66261909a84e2be63cacb | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_ILC-NK_cell|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.09e-03 | 192 | 16 | 2 | c5f77c2103841505d13e09173549811312ef2f01 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 2.09e-03 | 192 | 16 | 2 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | ILEUM-non-inflamed-(1)_CD8_Trm|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.09e-03 | 192 | 16 | 2 | a9f89043c97cd2b0ba165e69ee5681094410af37 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_NK|Lung / Manually curated celltypes from each tissue | 2.11e-03 | 193 | 16 | 2 | a98ee519e0da93ae4a2dcdda1ee8b4138dec131b | |
| ToppCell | (5)_Plasma_IgG|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 2.11e-03 | 193 | 16 | 2 | a94ebb3bca62970d5d17b0234893918ee6b7b808 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_T_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.11e-03 | 193 | 16 | 2 | a594f89a18273797506287d9e22f72abe53e4920 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.13e-03 | 194 | 16 | 2 | 8ef0b71fef5b84cfd04973f891215333e7035d1d | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4/8-lo|bone_marrow / Manually curated celltypes from each tissue | 2.13e-03 | 194 | 16 | 2 | afbf3cecffa2c5e830ebca5db950528cc78fd269 | |
| ToppCell | B_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 2.13e-03 | 194 | 16 | 2 | 22b87fe2bb84632ddcef8f1d7742021728e2246d | |
| ToppCell | (5)_Plasma_IgM|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 2.13e-03 | 194 | 16 | 2 | 47c0f7a1c39ba0836e40ea3ca8066457c0951575 | |
| ToppCell | 10x5'v1-week_14-16-Hematopoietic-HSC/MPP_and_pro-MEP|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.13e-03 | 194 | 16 | 2 | 7ad255fa357d41fe57ed803314de46a6577a1283 | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_B-B_lineage-immature_B_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.15e-03 | 195 | 16 | 2 | ecaaa3d071e763c40d05d088fbf9e8ca06f78f47 | |
| ToppCell | droplet-Marrow-BM-1m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-03 | 195 | 16 | 2 | 637b06ef3967b03f7165d102d316e8b7161a817d | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-T_lymphocytic-type_I_NK_T_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.15e-03 | 195 | 16 | 2 | 0a72b8446399807ace5b6c72f865bb40dbd9e92d | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-Trm_Th1/Th17|lymph-node_spleen / Manually curated celltypes from each tissue | 2.15e-03 | 195 | 16 | 2 | c60982804a74dbe6607c021799ca74af2204aba8 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-immature_B_cell|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.18e-03 | 196 | 16 | 2 | 9a6e4eea19348a6e3379d3b872456ab6280cb74f | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD8-Trm_gut_CD8|GI_small-bowel / Manually curated celltypes from each tissue | 2.18e-03 | 196 | 16 | 2 | 528622874692d7d65c905738b078ab53acef5846 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD8|GI_small-bowel / Manually curated celltypes from each tissue | 2.18e-03 | 196 | 16 | 2 | 3f5bf202c5d8c15072255c133793c8ee6e8d932f | |
| ToppCell | (2)_B_cells-(2)_Plasma_cells|(2)_B_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.18e-03 | 196 | 16 | 2 | cc4f59b885d58e43471e85c51d8e366e68d10846 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.18e-03 | 196 | 16 | 2 | a9157809122e6fc5783a291522f103bef30943e4 | |
| ToppCell | Megakaryocytic-erythropoietic-MEP|Megakaryocytic-erythropoietic / Lineage, cell class and subclass | 2.18e-03 | 196 | 16 | 2 | f90e7fe3a7b2fff30d01a25cc500876861c2e4f1 | |
| ToppCell | Megakaryocytic-erythropoietic-MEP-MEP|Megakaryocytic-erythropoietic / Lineage, cell class and subclass | 2.18e-03 | 196 | 16 | 2 | 4e97010185fa9392da8f69e7b2a7395bf063f8ff | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD8|bone_marrow / Manually curated celltypes from each tissue | 2.18e-03 | 196 | 16 | 2 | 5c9ed3c6e3cbd43b52f0291b5c26dd7f9fadf3da | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 2.20e-03 | 197 | 16 | 2 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_B-B_lineage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.20e-03 | 197 | 16 | 2 | 7290f05d0b8465637420119941bcbf2fae44a7e4 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.20e-03 | 197 | 16 | 2 | 268ca646f4a7466709c2c8b6ca56cf1344f3ef3e | |
| Computational | RNA splicing. | 1.50e-07 | 65 | 9 | 4 | MODULE_183 | |
| Computational | Neighborhood of TERF1 | 1.70e-07 | 67 | 9 | 4 | MORF_TERF1 | |
| Computational | Neighborhood of DENR | 8.28e-06 | 51 | 9 | 3 | GNF2_DENR | |
| Computational | Neighborhood of XRCC5 | 2.57e-05 | 235 | 9 | 4 | MORF_XRCC5 | |
| Computational | Genes in the cancer module 32. | 2.84e-05 | 241 | 9 | 4 | MODULE_32 | |
| Computational | Neighborhood of HDAC1 | 3.49e-05 | 254 | 9 | 4 | MORF_HDAC1 | |
| Computational | Neighborhood of DEK | 4.07e-05 | 264 | 9 | 4 | MORF_DEK | |
| Computational | Neighborhood of BUB3 | 4.91e-05 | 277 | 9 | 4 | MORF_BUB3 | |
| Computational | Neighborhood of APEX1 | 4.91e-05 | 92 | 9 | 3 | GNF2_APEX1 | |
| Computational | Transcription. | 5.58e-05 | 96 | 9 | 3 | MODULE_124 | |
| Computational | Neighborhood of GNB1 | 7.16e-05 | 305 | 9 | 4 | MORF_GNB1 | |
| Computational | Neighborhood of HDAC1 | 8.38e-05 | 110 | 9 | 3 | GNF2_HDAC1 | |
| Computational | Neighborhood of DNMT1 | 1.03e-04 | 118 | 9 | 3 | MORF_DNMT1 | |
| Computational | Neighborhood of RAD23A | 1.20e-04 | 348 | 9 | 4 | MORF_RAD23A | |
| Computational | Neighborhood of HAT1 | 3.32e-04 | 175 | 9 | 3 | MORF_HAT1 | |
| Computational | Neighborhood of TDG | 3.66e-04 | 35 | 9 | 2 | GNF2_TDG | |
| Computational | Neighborhood of ANP32B | 4.09e-04 | 37 | 9 | 2 | GNF2_ANP32B | |
| Computational | Neighborhood of RAF1 | 5.53e-04 | 43 | 9 | 2 | GCM_RAF1 | |
| Computational | Neighborhood of ACP1 | 5.74e-04 | 211 | 9 | 3 | MORF_ACP1 | |
| Computational | Neighborhood of ELAC2 | 6.33e-04 | 46 | 9 | 2 | GNF2_ELAC2 | |
| Computational | Neighborhood of DEK | 1.01e-03 | 58 | 9 | 2 | GNF2_DEK | |
| Computational | Neighborhood of SMC1L1 | 1.15e-03 | 62 | 9 | 2 | MORF_SMC1L1 | |
| Computational | Neighborhood of DDX5 | 1.26e-03 | 65 | 9 | 2 | GCM_DDX5 | |
| Computational | Neighborhood of HDAC2 | 1.31e-03 | 280 | 9 | 3 | MORF_HDAC2 | |
| Computational | Neighborhood of RBBP6 | 1.46e-03 | 70 | 9 | 2 | GNF2_RBBP6 | |
| Computational | Neighborhood of CDK2 | 1.55e-03 | 72 | 9 | 2 | MORF_CDK2 | |
| Computational | Neighborhood of KPNB1 | 1.59e-03 | 73 | 9 | 2 | GNF2_KPNB1 | |
| Computational | Neighborhood of UBE2N | 2.67e-03 | 95 | 9 | 2 | MORF_UBE2N | |
| Computational | Neighborhood of CSNK2B | 2.90e-03 | 99 | 9 | 2 | GCM_CSNK2B | |
| Computational | Neighborhood of RRM1 | 3.07e-03 | 102 | 9 | 2 | MORF_RRM1 | |
| Computational | Neighborhood of DAP3 | 4.16e-03 | 119 | 9 | 2 | GNF2_DAP3 | |
| Computational | Neighborhood of DFFA | 4.87e-03 | 129 | 9 | 2 | GCM_DFFA | |
| Computational | Neighborhood of AP3D1 | 4.94e-03 | 130 | 9 | 2 | MORF_AP3D1 | |
| Computational | Neighborhood of FBL | 5.71e-03 | 140 | 9 | 2 | MORF_FBL | |
| Computational | Neighborhood of RFC4 | 6.62e-03 | 151 | 9 | 2 | MORF_RFC4 | |
| Computational | Neighborhood of PPP1CC | 7.95e-03 | 166 | 9 | 2 | MORF_PPP1CC | |
| Computational | Neighborhood of G22P1 | 8.51e-03 | 172 | 9 | 2 | MORF_G22P1 | |
| Computational | Neighborhood of PRKDC | 1.04e-02 | 191 | 9 | 2 | MORF_PRKDC | |
| Computational | Neighborhood of ANP32B | 1.12e-02 | 198 | 9 | 2 | MORF_ANP32B | |
| Computational | Neighborhood of AATF | 1.24e-02 | 209 | 9 | 2 | MORF_AATF | |
| Computational | Neighborhood of UBE2I | 1.59e-02 | 238 | 9 | 2 | MORF_UBE2I | |
| Computational | Neighborhood of EIF3S2 | 1.69e-02 | 246 | 9 | 2 | MORF_EIF3S2 | |
| Drug | poly(G | 8.31e-09 | 114 | 15 | 5 | CID000439502 | |
| Disease | Epileptic encephalopathy | 1.19e-04 | 30 | 16 | 2 | C0543888 | |
| Disease | Intellectual Disability | 1.67e-03 | 447 | 16 | 3 | C3714756 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RGAGGSRQGGQPGAQ | 31 | O00555 | |
| GRGGTRGRGRGQGQN | 331 | O14979 | |
| GGYGQQDRGGRGRGG | 206 | P35637 | |
| RRADFNRGGGNGRGG | 371 | P35637 | |
| QGPENGRRGGFGSRG | 161 | Q9NZI8 | |
| NGRNPGGRGGNPRKG | 6 | Q13191 | |
| GKNQFNRGGGHRGRG | 696 | Q00839 | |
| GFNMRGGNFRGGAPG | 711 | Q00839 | |
| GGNFRGGAPGNRGGY | 716 | Q00839 | |
| GGAPGNRGGYNRRGN | 721 | Q00839 | |
| NRGGYNRRGNMPQRG | 726 | Q00839 | |
| NRRGNMPQRGGGGGG | 731 | Q00839 | |
| SNRGNYNRGGMPNRG | 766 | Q00839 | |
| GSRGGRGGPAQQQRG | 541 | O43390 | |
| GSLYRNGGQRGEGAG | 1251 | O14559 | |
| GQGMGRGSRPYRNRG | 466 | Q06787 | |
| QRGRQGDSGIPGYGQ | 1646 | A8TX70 | |
| GGGDANGGLRNYGYR | 241 | Q86UW8 | |
| GQRQQPGGRGGRSSG | 6 | A0A2R8Y619 | |
| NRGPPGGNRGGFQNR | 631 | Q9BUJ2 | |
| RGGGRGGFNKGQDQG | 51 | Q9NY12 | |
| GNRRGGQGYRPQGQK | 446 | Q86XZ4 | |
| GRGNNNRKGRGGNRG | 131 | Q5T6F2 |